Does this medication cause vision problems and slow down your movements or is it!
Question: Does this medication cause vision problems and slow down your movements or is it just me!?
I am on risperdal and since taking it it is as if I feel dizziness behind the eyes and I have trouble processing what I see at times!. Also it is as if one of my eyes is slightly turned in!. I did not notice but someone who saw my pic asked me if I was handicapped because of it!. Also, I feel as if I am going as fast as I can when in fact I am moving slower than other people!. I need to keep taking it for my schizophrenia but wonder if these side effects are normal!. Or could it mean I have another illness I do not know of!.Www@Answer-Health@Com
Answers:
I have taken ripserdal and gone through what you are talking about!. Had major major problems with withdrawal when I stopped!. Hate to be negative, but it gets way worse!. Have you lowered your dosage or missed a pill!? Please call your doc asap and make sure you are taken seriously, because you can get very, very sick if this continues!.Www@Answer-Health@Com
My eyeglass prescription changed suddenly, drastically, and permanently while I was on a particular antipsychotic!. To this day I can't wear those old glasses!. I had to get a new prescription!. As for the moving slow part you could have drug induced parkinsons!. There is a pill for that!.Www@Answer-Health@Com
I am currently taking 4 mg's of Risperdal per day for Tourette's and paranoia and I don't have any of the symptoms you've described!. Sometimes the Risperdal makes me feel jumpy at times, especially after I take it but no vision problems for me here!.Www@Answer-Health@Com
Call your doctor and discuss this with him,, It sounds like side effects, but I am not no doctor!. They have alot of other meds out there than can help, maybe your doctor can change it for you!.!. I would call him/her asap though!.!. I had to quit taking a couple in the past due to side effects, which can be harmful!. So plzzzzzz look into this!.!. Honestly!.!. Www@Answer-Health@Com
Risperdal
The following findings are based on the short-term, placebo-controlled, North American, premarketing trials for schizophrenia and acute bipolar mania, and are followed by a description of adverse events and other safety measures in short-term, placebo-controlled trials in pediatric patients treated for irritability associated with autistic disorder!. In patients with Bipolar I Disorder, treatment-emergent adverse events are presented separately for risperidone as monotherapy and as adjunctive therapy to mood stabilizers!.
Certain portions of the discussion below relating to objective or numeric safety parameters, namely dose-dependent adverse events, vital sign changes, weight gain, laboratory changes, and ECG changes are derived from studies in patients with schizophrenia!. However, this information is also generally applicable to bipolar mania and pediatric patients with autistic disorder!.
Other Adverse Events
Adverse event data elicited by a checklist for side effects from a large study comparing 5 fixed doses of RISPERDAL? (1, 4, 8, 12, and 16 mg/day) were explored for dose-relatedness of adverse events!. A Cochran-Armitage Test for trend in these data revealed a positive trend (p<0!.05) for the following adverse events: sleepiness, increased duration of sleep, accommodation disturbances, orthostatic dizziness, palpitations, weight gain, erectile dysfunction, ejaculatory dysfunction, orgastic dysfunction, asthenia/lassitude/increased fatigability, and increased pigmentation!.
Weight Changes
The proportions of RISPERDAL? and placebo-treated patients meeting a weight gain criterion of
The following findings are based on the short-term, placebo-controlled, North American, premarketing trials for schizophrenia and acute bipolar mania, and are followed by a description of adverse events and other safety measures in short-term, placebo-controlled trials in pediatric patients treated for irritability associated with autistic disorder!. In patients with Bipolar I Disorder, treatment-emergent adverse events are presented separately for risperidone as monotherapy and as adjunctive therapy to mood stabilizers!.
Certain portions of the discussion below relating to objective or numeric safety parameters, namely dose-dependent adverse events, vital sign changes, weight gain, laboratory changes, and ECG changes are derived from studies in patients with schizophrenia!. However, this information is also generally applicable to bipolar mania and pediatric patients with autistic disorder!.
Other Adverse Events
Adverse event data elicited by a checklist for side effects from a large study comparing 5 fixed doses of RISPERDAL? (1, 4, 8, 12, and 16 mg/day) were explored for dose-relatedness of adverse events!. A Cochran-Armitage Test for trend in these data revealed a positive trend (p<0!.05) for the following adverse events: sleepiness, increased duration of sleep, accommodation disturbances, orthostatic dizziness, palpitations, weight gain, erectile dysfunction, ejaculatory dysfunction, orgastic dysfunction, asthenia/lassitude/increased fatigability, and increased pigmentation!.
Weight Changes
The proportions of RISPERDAL? and placebo-treated patients meeting a weight gain criterion of
The consumer health information on answer-health.com is
for informational purposes only and is not a substitute for medical advice or
treatment for any medical conditions.
The answer content post by the user, if contains the copyright content please contact us, we will immediately remove it.
The answer content post by the user, if contains the copyright content please contact us, we will immediately remove it.
Copyright © 2007-2011 answer-health.com - Terms of Use - Contact us